{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:26:52Z","timestamp":1786606012073,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-026-01173-8","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:27:58Z","timestamp":1786602478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sequential changes in urinary crystal morphology in ethylene glycol poisoning: first human LV-SEM characterization of recovery-phase crystals"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-6551","authenticated-orcid":false,"given":"Hiroki","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Anan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"2","key":"1173_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.kint.2017.03.051","volume":"92","author":"DM Roberts","year":"2017","unstructured":"Roberts DM, Lea-Henry TN. Simplifying the hemodialysis prescription in patients with ethylene glycol poisoning. Kidney Int. 2017;92(2):291\u20133.","journal-title":"Kidney Int"},{"issue":"1","key":"1173_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/toxsci\/kfi062","volume":"84","author":"KE McMartin","year":"2005","unstructured":"McMartin KE, Wallace KB. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol Sci. 2005;84(1):195\u2013200.","journal-title":"Toxicol Sci"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.12659\/AJCR.908569","volume":"19","author":"HM Sheta","year":"2018","unstructured":"Sheta HM, Najami I, Christensen HD, Madsen JS. Rapid diagnosis of ethylene glycol poisoning by urine microscopy. Am J Case Rep. 2018;19:689\u201393.","journal-title":"Am J Case Rep"},{"issue":"1","key":"1173_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0002-9343(88)90024-1","volume":"84","author":"D Jacobsen","year":"1988","unstructured":"Jacobsen D, Hewlett TP, Webb R, Brown ST, Ordinario AT, McMartin KE. Ethylene glycol intoxication: evaluation of kinetics and crystalluria. Am J Med. 1988;84(1):145\u201352.","journal-title":"Am J Med"},{"issue":"4","key":"1173_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ki.2011.80","volume":"80","author":"YH Chen","year":"2011","unstructured":"Chen YH, Liu HP, Chen HY, Tsai FJ, Chang CH, Lee YJ, et al. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis\/urolithiasis. Kidney Int. 2011;80(4):369\u201377.","journal-title":"Kidney Int"},{"issue":"2","key":"1173_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13730-021-00658-y","volume":"11","author":"M Abe","year":"2022","unstructured":"Abe M, Furuichi M, Ishimitsu T, Tojo A. Analysis of purple urine bag syndrome by low vacuum scanning electron microscopy. CEN Case Rep. 2022;11(2):225\u201330.","journal-title":"CEN Case Rep"},{"issue":"1","key":"1173_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00240-023-01424-8","volume":"51","author":"AC Bauz\u00e1","year":"2023","unstructured":"Bauz\u00e1 AC, Grases F, Juli\u00e0 F. The power of desktop scanning electron microscopy with elemental analysis for analyzing urinary stones. Urolithiasis. 2023;51(1):50.","journal-title":"Urolithiasis"},{"issue":"3","key":"1173_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0736-4679(03)00203-8","volume":"25","author":"MY Woo","year":"2003","unstructured":"Woo MY, Greenway DC, Nadler SP, Cardinal P. Artifactual elevation of lactate in ethylene glycol poisoning. J Emerg Med. 2003;25(3):289\u201393.","journal-title":"J Emerg Med"},{"key":"1173_CR9","doi-asserted-by":"publisher","first-page":"106524","DOI":"10.1016\/j.phrs.2022.106524","volume":"186","author":"G Anan","year":"2022","unstructured":"Anan G, Hirose T, Kikuchi D, et al. Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation. Pharmacol Res. 2022;186:106524.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1173_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3949\/ccjm.54.4.289","volume":"54","author":"MR Verrilli","year":"1987","unstructured":"Verrilli MR, Deyling CL, Pippenger CE, Van Lente F, Vidt DG, Sivak ED. Fatal ethylene glycol intoxication. Report of a case and review of the literature. Cleve Clin J Med. 1987;54(4):289\u201395.","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"1173_CR11","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1111\/j.1464-410X.2010.09258.x","volume":"106","author":"T Wang","year":"2010","unstructured":"Wang T, Thurgood LA, Grover PK, Ryall RL. A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine. BJU Int. 2010;106(11):1768\u201374.","journal-title":"BJU Int"},{"issue":"10","key":"1173_CR12","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1021\/acsomega.7b00510","volume":"2","author":"XY Sun","year":"2017","unstructured":"Sun XY, Xu M, Ouyang JM. Effect of crystal shape and aggregation of calcium oxalate monohydrate on cellular toxicity in renal epithelial cells. ACS Omega. 2017;2(10):6039\u201352.","journal-title":"ACS Omega"},{"issue":"4","key":"1173_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrneph.2017.10","volume":"13","author":"SR Mulay","year":"2017","unstructured":"Mulay SR, Anders HJ. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nat Rev Nephrol. 2017;13(4):226\u201340.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1173_CR14","doi-asserted-by":"publisher","first-page":"064103","DOI":"10.1063\/5.0063714","volume":"15","author":"F Ibis","year":"2021","unstructured":"Ibis F, Yu TW, Penha FM, Ganguly D, Nuhu MA, van der Heijden AEDM, et al. Nucleation kinetics of calcium oxalate monohydrate as a function of pH, magnesium, and osteopontin concentration quantified with droplet microfluidics. Biomicrofluidics. 2021;15(6):064103.","journal-title":"Biomicrofluidics"},{"issue":"1","key":"1173_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.ASN.0000040593.93815.9D","volume":"14","author":"JA Wesson","year":"2003","unstructured":"Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol. 2003;14(1):139\u201347.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1173_CR16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1681\/ASN.2006010088","volume":"17","author":"CF Verkoelen","year":"2006","unstructured":"Verkoelen CF. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? J Am Soc Nephrol. 2006;17(6):1673\u201387.","journal-title":"J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01173-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:27:59Z","timestamp":1786602479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01173-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01173-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Institutional Review Board of the Tohoku Medical and Pharmaceutical University. It was conducted in accordance with the Declaration of Helsinki of the World Medical Association.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}